News

Pennsylvania Congressman defends role in opioid law

Written by Matthew Daly, The Associated Press | Oct 18, 2017 11:38 AM
tom_marino.jpg

Photo by Courtesy

(Washington, D.C.) -- President Donald Trump's former nominee to be the nation's drug czar is defending his role in writing a law that critics say weakened the government's authority to stop companies from distributing opioids.

Rep. Tom Marino, a Republican who represents Pennsylvania's 10th District, said he's proud of his work on the 2016 law, which passed without opposition in the House and Senate and was signed by President Barack Obama.

In a statement released by his office, Marino said the law will help "facilitate a balanced solution" by ensuring access to certain medications while allowing the Drug Enforcement Administration to prevent the sale and abuse of prescription drugs.

The former prosecutor withdrew on Tuesday as Trump's nominee to head the White House Office of National Drug Control Policy following reports by The Washington Post and CBS News about the law. Critics say the measure has undermined efforts to restrict the flow of pain pills that have led to tens of thousands of deaths.

Marino disputed that, saying he wanted to "insist on correcting the record regarding the false accusations and unfair reporting to which I have been subjected."

The Post reported Sunday that for years, some drug distributors were fined for repeatedly ignoring DEA warnings to shut down suspicious sales of hundreds of millions of pills, while the companies racked up billions of dollars in sales.

The new law makes it virtually impossible for the DEA to freeze suspicious narcotic shipments from the companies, according to the report. It cited internal DEA and Justice Department documents and an independent assessment by the DEA's chief administrative law judge.

Before the law was changed, the DEA was able to immediately prevent drugs from reaching the street based on its judgment that the drugs posed an "imminent danger" to a community.

Now, the agency must demonstrate that a company's actions represent "a substantial likelihood of an immediate threat," a much higher bar that officials say is difficult to meet.

Trump is under growing pressure to fulfill his pledge to declare the opioid epidemic a "national emergency," as a commission he's convened on the subject has urged him to do. Trump told reporters Monday that he will make the declaration official next week.

Trump told Fox News Radio on Tuesday that Marino "felt compelled" to step down from the job.

"He feels very strongly about the opioid problem and the drug problem, and Tom Marino said, 'Look, I'll take a pass,'" Trump said.

Democrats hailed Marino's withdrawal.

"We need a drug czar who has seen these devastating effects and who is passionate about ending this opioid epidemic," said Sen. Joe Manchin, D-W.Va., whose state has been ravaged by the drug crisis, which kills an estimated 142 people a day nationwide.

Manchin scolded the Obama administration for failing to "sound the alarm on how harmful that bill would be" to fight the opioid epidemic.

The Post reported that the drug industry worked behind the scenes with lobbyists and key members of Congress, including Marino, pouring more than a million dollars into their election campaigns.

This article has been updated. An earlier version appears below. 

(Washington, D.C.) -- President Donald Trump's former nominee to be the nation's drug czar is defending his role in writing a law that critics say weakened the government's authority to stop companies from distributing opioids.

Republican Rep. Tom Marino, who represents Pennsylvania's 10th district, says he's proud of his work on 2016 law. The measure passed without opposition in the House and Senate and was signed by President Barack Obama.

Marino says in a statement that the law will help "facilitate a balanced solution" by ensuring access to certain medications while allowing the Drug Enforcement Agency to prevent the sale and abuse of prescription drugs.

Marino withdrew Tuesday as Trump's nominee to head the White House Office of National Drug Control Policy following reports by The Washington Post and CBS News about the law.

Published in News

back to top

Give Now

Estate Planning

Support for WITF is provided by:

Become a WITF sponsor today »

Smart Talk

National Edward R. Murrow Awards

DuPont Columbia Awards

Support Local Journalism

Latest News from NPR

Support for WITF is provided by:

Become a WITF sponsor today »